Skip to main content
. 2016 Feb 29;14(1):74–78. doi: 10.9758/cpn.2016.14.1.74

Table 1.

Demographic and clinical characteristics of study participants

Drug Gender (n), male/female Age (yr) Duration of disease (yr)
Oxcarbazepine (n=27) 18/9 37.63±10.20 (27–48) 10.64±8.96 (0.5–41)
Levetiracetam (n=21) 8/13 35.76±13.14 (22–49) 8.28±8.61 (2–25)
Control group (n=42) 27/15 32.71±7.20 (25–49) -

Values are presented as number only or mean±standard deviation (range).